Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Monoinfection-Reference-Cited by-同舟云学术

Tenofovir Alafenamide for the Treatment of Chronic Hepatitis B Monoinfection

Published:2018-09-09 Issue:10 Volume:38 Page:1051-1057
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Childs-Kean Lindsey M.¹^ORCID,Egelund Eric F.²,Jourjy Jacqueline³

Affiliation:

1. University of Florida College of Pharmacy; Gainesville Florida

2. University of Florida College of Pharmacy; Jacksonville Florida

3. University of Florida College of Pharmacy; Orlando Florida

Publisher

Wiley

Subject

Pharmacology (medical)

Link

Reference33 articles.

1. Centers for Disease Control and Prevention Hepatitis B FAQ's for health professionals https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#overview

4. Gilead Sciences, Inc Viread (tenofovir disoproxil fumarate) [product information] Foster City, CA 2017

5. Gilead Sciences, Inc Vemlidy (tenofovir alafenamide) [product information] Foster City, CA 2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Disease-modifying therapies;Clinical Aspects of Multiple Sclerosis Essentials and Current Updates;2024